Perrin L. French, MD
Psychiatry · Palo Alto
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- Has dropped Medicare — you would pay privately
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. French’s office at (650) 515-5850 to ask if they take your plan before you enroll.
California Medical Board record
Licence G23857 · Current
Licensed to practise in California · since 1972 · expires 2027-06-30 · Johns Hopkins University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Drugs they prescribed that Part D paid
$23
Pharmacies billed $23 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 27) in 2024. Too few prescriptions to compare fairly with other clinicians.
27 generic and 0 brand-name prescriptions · $23 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Sertraline | 17 | $17 | $1 |
Year by year
| 2024 | 27 | None | 0% (0) | 0% | $23 |
| 2023 | 19 | None | 0% (0) | 0% | $278 |
| 2021 | 28 | None | 0% (0) | None | $1,281 |
| 2020 | 23 | None | 0% (0) | None | $1,037 |
| 2019 | 21 | None | 0% (0) | None | $5,969 |
| 2017 | 76 | None | 0% (0) | 0% | $1,037 |
| 2016 | 105 | None | 0% (0) | 0% | $1,697 |
| 2015 | 94 | 15 | 0% (0) | 16% | $6,058 |
| 2014 | 56 | 11 | 0% (0) | None | $2,726 |
| 2013 | 75 | 12 | 0% (0) | None | $5,960 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2017: 3 drugs
| Clonazepam | 17 | $207 | $12 |
| Quetiapine | 15 | $81 | $5 |
| Lorazepam | 11 | $48 | $4 |
2016: 3 drugs
| Clonazepam | 30 | $311 | $10 |
| Quetiapine | 25 | $132 | $5 |
| Venlafaxine Hcl Er | 11 | $130 | $12 |
2015: 2 drugs
| Doxepin | 11 | $752 | $68 |
| Clonazepam | 14 | $107 | $8 |
Money from drug and device companies
$129 in 2025
| 2025 | 1 | 1 | None | $129 |
| 2024 | 1 | 2 | None | $42 |
| 2019 | 1 | 1 | None | $90 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| E.R. Squibb & Sons L.L.C. | Cobenfy | $129 | 1 payment
|
See the published payment
| E.R. Squibb & Sons L.L.C. | Meals · 2025-09-09 | Cobenfy | $129 |
See earlier years (2024, 2019)
2024: $42
| E.R. Squibb & Sons L.L.C. | Cobenfy | $42 | 2 payments
|
2019: $90
| Otsuka America Pharmaceutical | Rexulti | $90 | 1 payment
|
Professional record
- NPI
- 1780762369
- Licence
- CA G23857California G23857: Current · expires 2027-06-30
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00G238570
- Taxonomy
- Psychiatry (2084P0800X)
- Mailing address
- 605 Cowper St, Palo Alto, CA, 94301
- NPI first listed
- 2006-11-01
- NPI last updated
- 2022-07-21
This is when the NPI record was last certified, not a medical board exam.